MDCalc

2018 Leibovich Model for Renal Cell Carcinoma (RCC)

Predicts progression-free and cancer-specific survival in patients with renal cell carcinoma (RCC).

Separate calculators are available for clear cell (ccRCC), papillary (papRCC), and chromophobe (chrRCC) histologies; always select the version that matches the surgical specimen.

Type of RCC

Result:

Please fill out required fields.
Advice
  • This tool should be used in conjunction with clinical expertise, specialist consultation, and patient preferences to direct treatment and monitoring.
  • In general, risk estimates can guide:
    • Surveillance intensity.
    • Adjuvant therapy use, including immunotherapies.
    • Prognosis counselling.
    • Comorbidity management.
  • Scores may also identify individuals who are appropriate for clinical trials.